2015 | Locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy | 김규보 | Article |
2016 | Mechanism-based management for mucositis: Option for treating side effects without compromising the efficacy of cancer therapy | 권영주 | Review |
2022 | Near-maximum rib dose is the most relevant risk factor for ipsilateral spontaneous rib fracture: a dosimetric analysis of breast cancer patients after radiotherapy | 김규보 | Article |
2017 | Optimal Adjuvant Treatment for Curatively Resected Thoracic Esophageal Squamous Cell Carcinoma: A Radiotherapy Perspective | 박경란 | Article |
2022 | Optimal Definition of Biochemical Recurrence in Patients Who Receive Salvage Radiotherapy Following Radical Prostatectomy for Prostate Cancer | 정송미 | Article |
2021 | Outcome of radiotherapy for clinically overt metastasis to the internal mammary lymph node in patients receiving neoadjuvant chemotherapy and breast cancer surgery | 김규보 | Article |
2023 | Patterns and Longitudinal Changes in the Practice of Breast Cancer Radiotherapy in Korea: Korean Radiation Oncology Group 22-01 | 김규보 | Article |
2023 | Patterns of locoregional recurrences and suggestion of the clinical target volume in resected perihilar extrahepatic cholangiocarcinoma | 김규보; 박영희; 정원근 | Article |
2022 | Postmastectomy Radiation Therapy for Node-Negative Breast Cancer of 5 cm or Larger Tumors: A Multicenter Retrospective Analysis (KROG 20-03) | 김규보; 정원근 | Article |
2017 | Postmastectomy radiotherapy in patients with pT1-2N1 breast cancer treated with taxane-based chemotherapy: A retrospective multicenter analysis (KROG 1418) | 김규보; 박경란 | Article |
2017 | Radiation therapy for malignant phyllodes tumor of the breast: An analysis of SEER data | 김규보 | Article |
2018 | Real-time tumor motion tracking in 3D using planning 4D CT images during image-guided radiation therapy | 최장환 | Article |
2019 | Risk factors for recurrence of malignant phyllodes tumors of the breast | 김규보 | Article |
2023 | Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: A systematic review and meta-analysis | 김규보 | Review |
2017 | Selective Radiation Therapy for Ductal Carcinoma In Situ Following Breast-Conserving Surgery According to Age and Margin Width: Korean Radiation Oncology Group 11-04 and 16-02 Studies | 김규보 | Article |
2022 | Shielding evaluator actual treatment leaf: A program for automatic shielding assessment using patient data | 안소현 | Article |
2019 | The Benefit of Post-Mastectomy Radiotherapy in ypN0 Patients after Neoadjuvant Chemotherapy According to Molecular Subtypes | 김규보 | Article |
2019 | The Characteristics of Local Recurrence After Breast-Conserving Surgery Alone for Malignant and Borderline Phyllodes Tumors of the Breast (KROG 16-08) | 김규보 | Article |
2015 | The inflammasome accelerates radiation-induced lung inflammation and fibrosis in mice | 이윤실 | Article |
2017 | The TLR7 agonist imiquimod induces anti-cancer effects via autophagic cell death and enhances anti-tumoral and systemic immunity during radiotherapy for melanoma | 이윤실 | Article |
2021 | Time-sequential change in immune-related gene expression after irradiation in glioblastoma: next-generation sequencing analysis | 김이준 | Article |
2023 | Total neoadjuvant therapy with short-course radiotherapy Versus long-course neoadjuvant chemoradiotherapy in Locally Advanced Rectal cancer, Korean trial (TV-LARK trial): study protocol of a multicentre randomized controlled trial | 남은미 | Article |
2022 | Treatment Outcomes according to the EndoPredict Score in ER-Positive, HER2-Negative Early Breast Cancer | 문병인; 김규보; 정원근 | Article |